Evidence map›Paper›PMID 28290224›Full record

ReviewJournal of diabetes science and technology2017

Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.

David L Levitt, Kristi D Silver, Elias K Spanakis

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of diabetes science and technology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04230694 nacompletednot on this mapstarted 2021, after this paper: background citation

Continuous Glucose Monitoring of Hospitalized Patients With Diabetes: A Pilot Study to Establish Evidence

TypeinterventionalSponsorBaylor Research InstituteRan2021 to 2024Enrolled40ConditionsDiabetes, Diabetes Mellitus, Glucose, High Blood, Glucose, Low BloodArmsDexcom Generation 6 CGM (Dexcom Gen6) device
NCT04871438 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Flash CONtinous Glucose Monitoring in TRansition to Outpatient: Libre for Type 2 Diabetes Mellitus (CONTROL-DM)

TypeinterventionalSponsorWoodlands HospitalRan2021 to 2022Enrolled34ConditionsType 2 Diabetes Treated With InsulinArmsFlash glucose monitoring
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Reliability of Inpatient CGM: Comparison to Standard of Care.Journal of diabetes science and technology · 2023
    Article
  7. Article
  8. Consumer Wearables for Patient Monitoring in Otolaryngology: A State of the Art Review.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2022
    Review
  9. Continuous glucose monitoring in the hospital: an update in the era of COVID-19.Current opinion in endocrinology, diabetes, and obesity · 2022
    Review
  10. Article
  11. Inpatient Hyperglycemia Management and COVID-19.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Glucose Management Technologies for the Critically Ill.Journal of diabetes science and technology · 2019
    Review
  16. Advancing the Use of CGM Devices in a Non-ICU Setting.Journal of diabetes science and technology · 2019
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David L Levitt1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Kristi D Silver1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Elias K Spanakis1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland, Baltimore · USUnited States Department of Veterans Affairs · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuous glucose monitoring (CGM) is commonly used in the outpatient setting to improve diabetes management. CGM can provide real-time glucose trends, detecting hyperglycemia and hypoglycemia before the onset of clinical symptoms. In 2011, at the time the Endocrine Society CGM guidelines were published, the society did not recommend inpatient CGM as its efficacy and safety were unknown. While many studies have subsequently evaluated inpatient CGM accuracy and reliability, glycemic outcome studies have not been widely published. In the non-ICU setting, investigational CGM studies have commonly blinded providers and patients to glucose data. Retrospective review of the glucose data reflects increased hypoglycemia detection with CGM. In the ICU setting, data are inconsistent whether CGM can improve glycemic outcomes. Studies have not focused on hospitalized patients with type 1 diabetes mellitus, the population most likely to benefit from inpatient CGM. This article reviews inpatient CGM glycemic outcomes in the non-ICU and ICU setting.

Indexed as

InpatientsBlood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1HumansBlood GlucoseCGMcontinuous glucose monitoringhospitalinpatienttype 1 diabetestype 2 diabetes

Identifiers

PMID28290224
PMCPMC5950986
OpenAlexW2739940341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.